Autoplay
Autocomplete
Previous Lesson
Complete and Continue
Legislation June 2025
Question
Question
Question 1 - Drug Classification
Question
Guide to Class Entries 2025
a) Linctus containing 12.5mg/5ml diphenhydramine hydrochloride, 125mg/5ml ammonium chloride and 50mg/5ml sodium citrate
b) A suspension containing 100mg/5ml ibuprofen
c) Ear drop - diethanolamine fusidate, framycetin sulfate, nystatin and prednisolone
d) Topical solution - methyl salicylate, menthol, camphor, thymol, chlorphenamine maleate and nonivamide
e) 💊 Bromhexine, caffeine, pentoxyverine citrate, chlorphenamine, lysozyme hydrochloride, paracetamol and phenylephrine
f) 💊 Empagliflozin and metformin hydrochloride
g) 💊 Oxycodone and naloxone
h) 💊 Praziquantel, oxantel embonate and pyrantel embonate
i) Solution - Ammonium bicarbonate, ipecacuanha tincture, anise water, camphor water and liquorice liquid extract
j) Cream - fusidic acid and hydrocortisone
k) Vitamin B and C injection
l) Cream containing 0.25% w/w desoximetasone
m) Syrup - dextromethorphan, pseudoephedrine, promethazine
n) Syrup - codeine phosphate, ephedrine, chlorphenamine, cocillana, senega liquid and squill liquid extract
o) Mupirocin ointment
p) Mouthwash benzydamine and chlorhexidine gluconate
Summary
B) Regulation 8 and Schedule 2 poisons
C) Schedule 3 exemptions
PPR Classification of P1DDs
Question 2 - Undesirable Medical Advertisements Ordinance (UMAO)
Question
a) Definitions
b) Orally consumed product
Question 3 - Nicotine PPR regulation
Question
a) Definitions
b) Nicotine
Question 4 - Manufacturers
Question
a) Definitions
b) Authorised Person
c) Statutory requirements
Question 5 - Dangerous Drugs
Question
a) Definition
b) Registered Medical Practitioner
l) Cream containing 0.25% w/w desoximetasone
Lesson content locked
If you're already enrolled,
you'll need to login
.
Enroll in Course to Unlock